Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04495738 · ClinicalTrials.gov registry record · NA

Infant Formula and Toddler Drink Feeding Intervention

A NA study, sponsored by Abbott Nutrition.

Terminated
Registry status
NA
Development phase
168
Enrollment target

NCT04495738: Clinical Trial NA study, sponsored by Abbott Nutrition.

NCT04495738 is a NA study that was terminated before completion, run by Abbott Nutrition. The registered enrollment target is 168 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04495738, a NA study, was terminated before completion, sponsored by Abbott Nutrition.

TERMINATED
Registry status
NA
Development phase
168 participants
Enrollment target

Study Summary

The purpose of this randomized, multi-center, controlled, double-blind, parallel study is to evaluate the health and developmental outcomes of children fed a new infant formula and toddler drink through 24 months of age.

Primary Outcome

Adverse event reports

Interventions

  • OTHER Experimental Infant Formula
  • OTHER Control Infant Formula
  • OTHER Control Toddler Drink
  • OTHER Experimental Toddler Drink
  • OTHER Supplemental Formula for HM Group

Trial Details

FieldValue
Enrollment Target 168 participants
Start Date 2020-08-10
Est. Completion 2021-04-12
Phase NA
Abbott Nutrition

89 total trials

Why NCT04495738 stopped before completion

NCT04495738 is an interventional study that assigns participants to a tested intervention. The registered 168 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).

The record links to 0 conditions, and to 5 interventions - of which Experimental Infant Formula is the first listed.

NCT04495738 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04495738 about?

NCT04495738 is a clinical study titled "Infant Formula and Toddler Drink Feeding Intervention". The purpose of this randomized, multi-center, controlled, double-blind, parallel study is to evaluate the health and developmental outcomes of children fed a new infant formula and toddler drink through 24 months of age.

What is the current status of trial NCT04495738?

This trial is currently terminated. It is a NA study. The enrollment target is 168 participants. The study started on 2020-08-10. Estimated completion is 2021-04-12.

What interventions are being tested in trial NCT04495738?

The interventions under investigation include: Experimental Infant Formula (OTHER), Control Infant Formula (OTHER), Control Toddler Drink (OTHER), Experimental Toddler Drink (OTHER), Supplemental Formula for HM Group (OTHER).

Who is sponsoring clinical trial NCT04495738?

This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04495738's enrollment target sits among peer trials

168 619th of 2000 higher than 1,379 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02118922 · 168 participants

    A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia

  • NCT03536897 · 168 participants

    IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry

  • NCT04078230 · 168 participants · NA

    Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma

  • NCT04159168 · 168 participants · NA

    Facial Affect Sensitivity Training for Young Children With Callous-unemotional Traits

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04495738, the US trial registry maintained by the National Library of Medicine. NCT04495738 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.